TABLE 5-2 Annual Awards and Expenditures of Section 317 Direct Assistance (DA) Vaccine Purchase Funds (in millions of dollars)
	Year New Funds Re-awarded Fundsa Total Award Expenditures Percentage of Total Award Expendedb 1990 149.0 0.0 149.0 106.3 71% 1991 112.9 37.5 150.3 102.5 68% 1992 156.2 26.8 183.1 121.6 66% 1993 171.2 43.9 215.1 156.2 77% 1994 136.2 86.3 222.5 171.9 61% 1995c 83.1 74.3 157.4 96.3 59% 1996 133.3 11.0 144.2 111.2 77% 1997 124.0 34.7 158.7 128.4 81% 1998d 108.2 34.9 143.1 135.6 95% 1999 128.0 8.0 136.0 NA NA
NOTE: CDC notes that 1990 was the first year in which grants were administered centrally, instead of by regional offices. There is limited background information with which to substantiate these amounts, and as a result their accuracy is questionable. In 1994, an additional $30,672,686 in appropriated vaccine purchase funds was paid directly to the Department of the Treasury for floor stock excise taxes on behalf of all the grantees when the Vaccine Compensation Act was reauthorized. a Funds awarded in previous years but not obligated. b Based on year-end unobligated balances for 1990–1997 reported to CDC as of April 1, 1999. c $53 million rescinded from unobligated balances in fiscal year 1996 (comprising funds from 1993, 1994, and 1995). d CDC estimates for expenditures and percentage of 1998 award expended. SOURCE: Information provided by CDC.